Role of the PP2A-FoxO1 axis in Treg function and allergic airway inflammation Allergic airway inflammation, the precursor to allergic asthma, occurs when the immune system develops an inappropriate inflammatory response to innocuous antigens. In healthy individuals, immunogenic responses to innocuous foreign antigens are dampened by peripheral tolerogenic mechanisms. Understanding why peripheral tolerance is either not elicited or overpowered in individuals with allergic asthma could elucidate new therapeutic targets. We propose that altered signaling and intrinsic dysfunction of T regulatory cells is partially responsible for the inadequate tolerogenic response in individuals with allergic airway inflammation. FoxO1 is a transcription factor critical for normal T regulatory cell function and PP2A is a serine/threonine phosphatase. Our studies focus on the role of the PP2A-FoxO1 axis in mediating T regulatory cell function and the control of allergic airway inflammation. Our preliminary data suggest that PP2A promotes FoxO1 function by mediating its dephosphorylation. Furthermore, we have observed that PP2A expression is decreased in the mediastinal lymph nodes of mice with allergic airway inflammation, recapitulating a similar finding in patients with allergic asthma. We hypothesize that PP2A-FoxO1 axis is an important component of normal T regulatory cell function and that decreased PP2A expression in the context of allergic airway inflammation could lead to T regulatory cell dysfunction, potentially exacerbating disease.
In Aim1, we will investigate the PP2A-FoxO1 axis function in Treg cells using a combination of pharmacologic and genetic rescue approaches.
In Aim2, we will use knockout mice and adoptive transfers in a model of allergic airway inflammation to test how the activity of the PP2A-FoxO1 axis in T regulatory cells affects allergic airway inflammation. Collectively, we expect these studies will provide new insights on Treg cell function, tolerance to common allergens, and airway inflammation

Public Health Relevance

Role of the PP2A-FoxO1 axis in Treg function and allergic airway inflammation Asthma is a growing public health concern both within the United States and abroad. In healthy individuals, the immune system becomes tolerant to most normal allergens, while in allergic and asthmatic patients this is not the case. Our studies focus on a signaling pathways in T regulatory cells, which control allergic inflammation of the airways, and are expected to provide insights on the generation of tolerance to allergens and in turn, the development of better therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Individual Predoctoral NRSA for M.D./Ph.D. Fellowships (ADAMHA) (F30)
Project #
5F30HL126385-03
Application #
9288211
Study Section
Special Emphasis Panel (ZRG1-F07-J (20)L)
Program Officer
Tigno, Xenia
Project Start
2015-06-01
Project End
2018-10-31
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
3
Fiscal Year
2017
Total Cost
$48,576
Indirect Cost
Name
University of Virginia
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Penberthy, Kristen K; Lysiak, Jeffrey J; Ravichandran, Kodi S (2018) Rethinking Phagocytes: Clues from the Retina and Testes. Trends Cell Biol 28:317-327
Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja et al. (2017) Ex vivo modulation of the Foxo1 phosphorylation state does not lead to dysfunction of T regulatory cells. PLoS One 12:e0173386
Penberthy, Kristen K; Rival, Claudia; Shankman, Laura S et al. (2017) Context-dependent compensation among phosphatidylserine-recognition receptors. Sci Rep 7:14623
Lee, Chang Sup; Penberthy, Kristen K; Wheeler, Karen M et al. (2016) Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo. Immunity 44:807-20
Penberthy, Kristen K; Ravichandran, Kodi S (2016) Apoptotic cell recognition receptors and scavenger receptors. Immunol Rev 269:44-59